Robin L Davies

Title: The Contributions of Inventor Robin L. Davies in Cell Line Development

Introduction

Robin L. Davies, based in Amherst, Virginia, is an accomplished inventor recognized for his significant contributions to the field of biotechnology. With a focus on human cell lines, he has made strides in research that impacts mutagenicity, toxicity, and metabolism studies.

Latest Patents

Robin L. Davies holds one notable patent that underscores his expertise. The patent is for a human cell line that stably expresses five complementary DNA sequences (cDNAs) encoding various cytochrome P450 enzymes. This innovative cell line, referred to as MCL-5, expresses cytochrome P450 IA1, IA2, IIA3, IIIA4, and IIE1, as well as microsomal epoxide hydrolase. The cell line's ability to facilitate advanced studies in drug metabolism makes it a valuable tool in the scientific community.

Career Highlights

Davies is employed by Gentest Corporation, a company renowned for its advancements in drug discovery and development technologies. His work at Gentest has positioned him as a key figure in the creation of highly relevant research tools, which aid in assessing the safety and efficacy of new pharmaceuticals.

Collaborations

Throughout his career, Robin has collaborated with esteemed colleagues, including Charles L. Crespi and Bruce W. Penman. These collaborations have fostered a productive environment for innovation and research, aligning with Gentest's mission to provide high-quality scientific solutions.

Conclusion

Robin L. Davies exemplifies the spirit of innovation in the biotechnological field. His patent for a stable human cell line is a testament to his dedication and skill, contributing significantly to research that aids in understanding human metabolism and toxicity. The collaborations and work at Gentest Corporation further reflect the impact of his pioneering efforts on the scientific landscape.